Gene · 3003
Papers2,892
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,261 to 1,280 of 2,892
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A spotlight on HCV and SARS-CoV-2 co-infection and brain function. | Pharmacol Biochem Behav | 2022 | 35561837 | PubTator, text mining | PubMed |
| Single-cell sequencing reveals the heterogeneity and intratumoral crosstalk in human endometrial cancer. | Cell Prolif | 2022 | 35560676 | PubTator, text mining | PubMed |
| Intratumoral therapies and in-situ vaccination for melanoma. | Hum Vaccin Immunother | 2022 | 35559766 | PubTator, text mining | PubMed |
| Neoadjuvant chemoradiation alters the immune microenvironment in pancreatic ductal adenocarcinoma. | Oncoimmunology | 2022 | 35558160 | PubTator, text mining | PubMed |
| Dissecting Intra-Tumoral Changes Following Immune Checkpoint Blockades in Intrahepatic Cholangiocarcinoma via Single-Cell Analysis. | Front Immunol | 2022 | 35558087 | PubTator, text mining | PubMed |
| Sequential Single-Cell Transcriptional and Protein Marker Profiling Reveals TIGIT as a Marker of CD19 CAR-T Cell Dysfunction in Patients with Non-Hodgkin Lymphoma. | Cancer Discov | 2022 | 35554512 | PubTator, text mining | PubMed |
| TMPRSS12 Functions in Meiosis and Spermiogenesis and Is Required for Male Fertility in Mice. | Front Cell Dev Biol | 2022 | 35547804 | PubTator, text mining | PubMed |
| Dynamic response landscape of immune cells identified immune dysfunction which predicts disease progression in COVID-19 infected patients. | Int J Biol Sci | 2022 | 35541915 | PubTator, text mining | PubMed |
| An activation to memory differentiation trajectory of tumor-infiltrating lymphocytes informs metastatic melanoma outcomes. | Cancer Cell | 2022 | 35537413 | PubTator, text mining | PubMed |
| Single-cell profiling reveals periventricular CD56bright NK cell accumulation in multiple sclerosis. | Elife | 2022 | 35536009 | PubTator, text mining | PubMed |
| Mechanisms of Action of Ozone Therapy in Emerging Viral Diseases: Immunomodulatory Effects and Therapeutic Advantages With Reference to SARS-CoV-2. | Front Microbiol | 2022 | 35531273 | PubTator, text mining | PubMed |
| The Significance of Tumor Microenvironment Score for Breast Cancer Patients. | Biomed Res Int | 2022 | 35528180 | PubTator, text mining | PubMed |
| ADAM10 and ADAM17 promote SARS-CoV-2 cell entry and spike protein-mediated lung cell fusion. | EMBO Rep | 2022 | 35527514 | PubTator, text mining | PubMed |
| Single-cell RNA sequencing in silent corticotroph tumors confirms impaired POMC processing and provides new insights into their invasive behavior. | Eur J Endocrinol | 2022 | 35521707 | PubTator, text mining | PubMed |
| SARS-CoV-2 Employ BSG/CD147 and ACE2 Receptors to Directly Infect Human Induced Pluripotent Stem Cell-Derived Kidney Podocytes. | Front Cell Dev Biol | 2022 | 35517495 | PubTator, text mining | PubMed |
| Mapping Breast Cancer Microenvironment Through Single-Cell Omics. | Front Immunol | 2022 | 35514975 | PubTator, text mining | PubMed |
| Multi-Platform Omics Analysis Reveals Molecular Signatures for Pathogenesis and Activity of Systemic Lupus Erythematosus. | Front Immunol | 2022 | 35514958 | PubTator, text mining | PubMed |
| CCL22 mutations drive natural killer cell lymphoproliferative disease by deregulating microenvironmental crosstalk. | Nat Genet | 2022 | 35513723 | PubTator, text mining | PubMed |
| The effects of SARS-CoV-2 infection on modulating innate immunity and strategies of combating inflammatory response for COVID-19 therapy. | J Biomed Sci | 2022 | 35505345 | PubTator, text mining | PubMed |
| High-throughput single-сell sequencing in cancer research. | Signal Transduct Target Ther | 2022 | 35504878 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3003/papers?page=64